Search

everythinglearnresearchcommunity

for

Search:↓

The QR 678 hair growth treatment was safe and effective for hair regrowth in men and women.

Lulican™ shampoo is more effective and better tolerated than Ketoconazole for treating scalp seborrheic dermatitis.

Bariatric surgery is safe and effective for treating adolescent obesity.

Depression is more common in infertile women with PCOS than those without.

Topical corticosteroids may be a safe and effective treatment for severe alopecia areata in children.

FDA-cleared devices may help treat hair loss, but more research needed; consult dermatologist before use.

The oral glucose tolerance test is effective in detecting abnormal glucose tolerance in Indian women with PCOS.

Combination of 17α-estradiol and minoxidil improves hair growth and reduces hair loss in most patients.

Curcumin spanlastics are the most effective for cancer therapy due to their strong antimicrobial, antioxidant, and antitumor effects.

The trial will test if YH0618 granule prevents hair loss in breast cancer patients during chemotherapy.

A new 3-D bioreactor system improves drug screening and reduces animal testing.

The conclusion is that small hair follicles cause baldness in macaques, and treatments like antiandrogens and minoxidil can prevent hair loss and promote regrowth.

Tinea capitis in a child was caused by a fungus from cats, highlighting the need for accurate diagnosis and treatment.

Activating STAT5 in the skin's dermal papilla is key for starting hair growth, regenerating hair follicles, and healing wounds.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

The document concludes that doctors should carefully consider off-label drug use in dermatology and always inform patients, while more research is needed on the safety and effectiveness of such practices.

Hair follicles help absorb and store topical compounds, aiding targeted drug delivery.

Adrenaline infiltration improves hair transplant efficiency and safety.

Nanotechnology shows promise for better drug delivery and cancer treatment.

Emulgels are promising for delivering drugs topically due to their easy spreadability and stability.

New gel formulas without ethanol and propylene glycol, containing a minoxidil-methyl-β-cyclodextrin complex, have been created for treating hair loss.

Antiyeast treatments work better for seborrheic dermatitis than steroids, and other findings include increased skin bacteria under plastic wrap, a nasal cell defect in Staphylococcus aureus carriers, quick resolution of certain skin reactions, high rubber latex allergy in spina bifida patients, and glyceryl monopentadecanoate's effectiveness for male hair loss.

A machine learning model called CATNIP can predict new uses for existing drugs, like using antidepressants for Parkinson's disease and a thyroid cancer drug for diabetes.

Smaller nanoparticles penetrate skin better, especially through hair follicles.

Targeting hair follicles can improve skin treatments and reduce side effects.

The human hair follicle can store topical compounds and be targeted for drug delivery with minimal side effects.

Nanoparticles around 600-700 nm can effectively enter and stay in hair follicles for days, which may help in delivering drugs to specific cells.

Hair follicles offer promising targets for delivering drugs to treat hair and skin conditions.

Regenerative pharmacology, which combines drugs with regenerative medicine, shows promise for repairing damaged body parts and needs more interdisciplinary research.

Two transplant patients on cyclosporine unexpectedly developed hair loss.